Myopathy ophthalmoplegia hypoacousia areflexia

Myopathy, Ophthalmoplegia, Hypoacusia, and Areflexia (MOHA) is a rare medical condition characterized by a combination of muscle weakness (Myopathy), paralysis of the eye muscles (Ophthalmoplegia), hearing loss (Hypoacusia), and the absence of reflexes (Areflexia). This condition falls under the broader category of Mitochondrial diseases, which are disorders caused by dysfunction of the mitochondria, the organelles that generate energy for the cell.

Symptoms and Diagnosis

The primary symptoms of MOHA include:

• Myopathy: Muscle weakness that can affect both the voluntary muscles used for movement and the involuntary muscles that control functions such as heartbeat and digestion.
• Ophthalmoplegia: Paralysis or weakness of the eye muscles, leading to difficulties in moving the eyes and sometimes resulting in double vision.
• Hypoacusia: A range of hearing impairments, from mild hearing loss to complete deafness.
• Areflexia: The absence or reduction of reflexes, a sign of peripheral nerve damage or severe muscle weakness.

Diagnosis of MOHA typically involves a combination of clinical evaluation, genetic testing to identify mutations in mitochondrial DNA, and other tests such as muscle biopsy, electromyography (EMG), and magnetic resonance imaging (MRI) of the brain and muscles.

Causes

MOHA is caused by mutations in the mitochondrial DNA that lead to dysfunction in the mitochondria. Since mitochondria are responsible for producing the energy that cells need to function, mitochondrial dysfunction can affect multiple systems in the body, leading to the diverse symptoms seen in MOHA.

Treatment

There is currently no cure for MOHA, and treatment focuses on managing symptoms and improving quality of life. This may include:

• Physical therapy to maintain muscle strength and mobility
• Hearing aids or cochlear implants for hypoacusia
• Regular monitoring and treatment of cardiac and respiratory function
• Nutritional support and supplements that may help improve mitochondrial function

Prognosis

The prognosis for individuals with MOHA varies depending on the severity of symptoms and the onset of the disease. Early intervention and supportive care can improve quality of life, but the progressive nature of mitochondrial diseases means that symptoms may worsen over time.

See Also

• Mitochondrial myopathy
• Kearns-Sayre syndrome
• Leber's hereditary optic neuropathy

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian